跳至主要内容
临床试验/ACTRN12619000532101
ACTRN12619000532101招募中4 期

The Utility of Magnesium in the Management of Atrial fibrillation with Rapid ventricular Response: A Randomised Controlled Trial (MagMAR study)

Eastern Health Foundation0 个研究点目标入组 200 人开始时间: 2019年4月3日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Greater than or equal to 18 years of age
  • 2. ECG at presentation to Emergency Department greater than or equal to a ventricular rate of 120
  • 3. Presenting complaint attributable to atrial fibrillation
  • 4. Able to give informed consent

排除标准

  • 1. Haemodynamically instability, in this study, defined as Systolic Blood Pressure less than 90mmHg
  • 2. Suspected acute myocardial infarction
  • 3. Overt sepsis suspected by treating clinician
  • 4. Known renal impairment (egfr <30)

研究者

发起方
Eastern Health Foundation

相似试验